NCT01999790

Brief Summary

Grave's ophthalmopathy is the most common cause of orbital disease in adults. The clinical presentation may vary between sub clinic symptoms to severe ones. The eyelid retraction is one of the most important signs of Grave's ophthalmopathy and can lead to cosmetic and functional problems. The eyelid retraction can be found in the inflammatory stage and in the chronic disease, when it is stable. It can be described when the upper lid is contouring the superior limbus or positioned above that. This condition can lead to dry eye symptoms, exposure keratitis and cosmetic issues. The treatment can may be surgical or medical. The medical treatment are usually based on controlling thyroid function and in the use of steroids, both are not specific for the lid retraction, but for the inflammation that is common in the disease. In the longstanding disease, surgery is the most efficient treatment. There are several described techniques, they are based on the concept of weakening the muscles that act on lid elevation (levator and Muller Muscle). Basically the techniques can be divided in two groups: the first with an anterior approach (with skin scar in the lid sulcus) and the second using a posterior approach (through the conjunctiva). In the literature there is no consensus in deciding the best technique, regarding cosmetic results, incidence of complications, hypo or hypercorrection. In this trial we propose to compare two distinct techniques that are already in clinical use. The blepharotomy uses a cutaneous approach and the other a conjunctival approach. The patients will be divided in two randomized groups and surgical expected outcomes, cosmetics outcomes and complications occurrence will be compared.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2012

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2012

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

November 17, 2013

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 3, 2013

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2014

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2015

Completed
Last Updated

December 3, 2013

Status Verified

November 1, 2013

Enrollment Period

2.8 years

First QC Date

November 17, 2013

Last Update Submit

November 25, 2013

Conditions

Keywords

upper lidexophthalmosgrave's orbitopathy

Outcome Measures

Primary Outcomes (1)

  • clinical measure of the Margin Reflex distance

    Assessment of the surgical correction effectiveness by measuring the eyelid lengthening

    6 months

Secondary Outcomes (2)

  • evaluation of ocular surface with OSDI (Ocular Surface Disease Index) questionnaire, clinical measures with Schirmmer test green lissamine and tear film breakup Time.

    6 months

  • From the patients digital photographs,computed assisted measurements of eyelid shape and contour will be performed.

    6 months

Study Arms (2)

Blepharothomy

EXPERIMENTAL

Patients treated with blepharotomy to correct upper lid retraction secondary to Grave's orbitopathy

Procedure: blepharotomy

posterior approach

EXPERIMENTAL

Patients treated with a posterior approach to correct upper lid retraction secondary to Grave's orbitopathy

Procedure: posterior approach

Interventions

blepharotomyPROCEDURE

upper eyelid surgery by blepharotomy

Blepharothomy

upper eyelid surgery by posterior approach

posterior approach

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \> 21 years old
  • controlled thyroid function
  • absence of strabismus
  • absence of other ocular pathology, such as high myopia
  • understanding the protocol and according the terms

You may not qualify if:

  • pregnancy
  • history of previous upper lid surgery
  • myasthenia gravis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital das Clinicas - FMUSP

São Paulo, São Paulo, 05403-010, Brazil

RECRUITING

Related Publications (2)

  • Pereira TS, Kuniyoshi CH, Leite CA, Gebrim EMMS, Monteiro MLR, Pieroni Goncalves AC. A Comparative Study of Clinical vs. Digital Exophthalmometry Measurement Methods. J Ophthalmol. 2020 Mar 23;2020:1397410. doi: 10.1155/2020/1397410. eCollection 2020.

  • Goncalves ACP, Nogueira T, Goncalves ACA, Silva LD, Matayoshi S, Monteiro MLR. A Comparative Study of Full-Thickness Blepharotomy Versus Transconjunctival Eyelid Lengthening in the Correction of Upper Eyelid Retraction in Graves' Orbitopathy. Aesthetic Plast Surg. 2018 Feb;42(1):215-223. doi: 10.1007/s00266-017-0978-9. Epub 2017 Oct 12.

MeSH Terms

Conditions

Graves OphthalmopathyExophthalmos

Condition Hierarchy (Ancestors)

Eye Diseases, HereditaryEye DiseasesGraves DiseaseOrbital DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesGoiterThyroid DiseasesEndocrine System DiseasesHyperthyroidismAutoimmune DiseasesImmune System Diseases

Study Officials

  • Allan p Goncalves, Dr

    Staff

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ana Carolina A Goncalves

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
staff

Study Record Dates

First Submitted

November 17, 2013

First Posted

December 3, 2013

Study Start

March 1, 2012

Primary Completion

December 1, 2014

Study Completion

February 1, 2015

Last Updated

December 3, 2013

Record last verified: 2013-11

Locations